Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Guille

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cancer Cell International|June 29, 2013
Signaling pathway switch in breast cancerArnaud Guille, Max Chaffanet, Daniel Birnbaum
Breast Cancer Research and Treatment|August 4, 2014
ESPL1 is a candidate oncogene of luminal B breast cancersPascal Finetti, Arnaud Guille, José Adelaide, et al.
Molecular Cancer|October 4, 2014
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterizationRenaud Sabatier, Pascal Finetti, Arnaud Guille, et al.
Briefings in Bioinformatics|January 19, 2025
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencingArnaud Guille, José Adélaïde, Pascal Finetti, et al.
BMC Research Notes|June 8, 2013
Djeen (Database for Joomla!'s Extensible Engine): a research information management system for flexible multi-technology project administrationOlivier Stahl, Hugo Duvergey, Arnaud Guille, et al.
Plos One|November 24, 2011
Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancerRenaud Sabatier, Pascal Finetti, José Adelaide, et al.
Journal for Immunotherapy of Cancer|February 2, 2026
Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis valueMaelle Picard, Arnaud Guille, Pascal Finetti, et al.
Ejhaem|May 19, 2023
Erythroleukemia: ClassificationNathalie Cervera, Arnaud Guille, José Adélaïde, et al.
Stem Cells (Dayton, Ohio)|July 30, 2014
Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcomeRita El Helou, Julien Wicinski, Arnaud Guille, et al.
Frontiers in Oncology|April 2, 2021
Case Report: Two Cases of Metastatic Pancreatoblastoma in Adults: Efficacy of Folfirinox and Implication of the Wnt/β-Catenin Pathway in Genomic AnalysisJean-Luc Raoul, Sandrine Oziel-Taieb, Thierry Lecomte, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cancer Cell International|June 29, 2013
Signaling pathway switch in breast cancerArnaud Guille, Max Chaffanet, Daniel Birnbaum
Breast Cancer Research and Treatment|August 4, 2014
ESPL1 is a candidate oncogene of luminal B breast cancersPascal Finetti, Arnaud Guille, José Adelaide, et al.
Molecular Cancer|October 4, 2014
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterizationRenaud Sabatier, Pascal Finetti, Arnaud Guille, et al.
Briefings in Bioinformatics|January 19, 2025
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencingArnaud Guille, José Adélaïde, Pascal Finetti, et al.
BMC Research Notes|June 8, 2013
Djeen (Database for Joomla!'s Extensible Engine): a research information management system for flexible multi-technology project administrationOlivier Stahl, Hugo Duvergey, Arnaud Guille, et al.
Plos One|November 24, 2011
Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancerRenaud Sabatier, Pascal Finetti, José Adelaide, et al.
Journal for Immunotherapy of Cancer|February 2, 2026
Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis valueMaelle Picard, Arnaud Guille, Pascal Finetti, et al.
Ejhaem|May 19, 2023
Erythroleukemia: ClassificationNathalie Cervera, Arnaud Guille, José Adélaïde, et al.
Stem Cells (Dayton, Ohio)|July 30, 2014
Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcomeRita El Helou, Julien Wicinski, Arnaud Guille, et al.
Frontiers in Oncology|April 2, 2021
Case Report: Two Cases of Metastatic Pancreatoblastoma in Adults: Efficacy of Folfirinox and Implication of the Wnt/β-Catenin Pathway in Genomic AnalysisJean-Luc Raoul, Sandrine Oziel-Taieb, Thierry Lecomte, et al.
Pageof 5